XML 40 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity (Tables)
9 Months Ended
Sep. 30, 2017
Shareholders' Equity [Abstract]  
Schedule of key assumptions used model at inception
  Inception  1/30/2017 
       
Stock Price  $0.00 - $60.00   $0.00 - $6.20 
Exercise Price $22.40  $22.40 
Term  .5 years   0.72 to 0.83 years 
Risk Free Interest Rate  .39% - .47%  0.81%
Volatility  60%  60%
Dividend Rate  0%  0%
Schedule of shortfall provision derivative liability
Balance – December 31, 2016 $2,093,623 
Fair Value Adjustment  844,112 
Extinguishment of Liability  (2,937,735)
Balance – June 30, 2017 $-

Schedule of offering issued dates
August 31, 2017 $1,043,000 
September 7, 2017  334,500 
September 14, 2017  32,500 
Total $1,410,000

Schedule of outstanding stock warrants
  Number of
Shares
  Average 
Exercise
Price
  Expiration
Date
Outstanding - December 31, 2016  148,777  $3.02   
Granted – January 30, 2017  3,112,871   5.16  January 31, 2022
Granted – June 30, 2017  575,000   1.90  June 30, 2022
Granted – June 30, 2017  100,000   2.19  June 30, 2022
Granted – July 11, 2017  75,000   1.90  July 11, 2022
Granted – July and August, 2017  2,227,800   1.44  July and August 2022
Exercised  148,777   3.02   
Outstanding, September 30, 2017  6,090,671  $3.40   
Warrants exercisable at September 30, 2017  6,090,671    
Schedule of the company's stock options

 

  Number of
Shares 
Underlying 
Options
  Weighted 
Average 
Exercise 
Price
  Weighted
Average
Grant Date
Fair Value
  Weighted Average
Remaining
Contractual
Life
  Aggregate 
Intrinsic 
Value (1)
 
                
Outstanding at December 31, 2016  12,250  $19.35  $4.78   4.84   - 
                     
For the nine months ended September 30, 2017                    
Forfeited  778   19.35  $4.78   -   - 
                     
Outstanding at September 30, 2017  11,472  $19.35  $4.78   4.10   - 
                     
Outstanding and Exercisable at September 30, 2017  3,660  $19.35  $4.78   4.10   - 

 

(1)The aggregate intrinsic value is based on the $1.25 closing price as of September 30, 2017 for the Company’s Common Stock.
Schedule of following information applies to options outstanding
Options Outstanding Options Exercisable 
Exercise Price Number of
Shares 
Underlying 
Options
  Weighted 
Average 
Remaining
Contractual 
Life
  Number 
Exercisable
  Exercise 
Price
 
$12.00  222   4.10   222  $12.00 
$20.00  11,250   4.10   3,438  $20.00 
   11,472   4.10   3,660